Total Funding
61
18
Total FundingNon-equity Assistance raised
Growth Score
-6 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
350896
Algiax Pharmaceuticals develops products for nervous system disease or dysfunction with a strong focus on neuropathic pain.
Birgit Hasse: Co Founder & Associate Head of Research & Development- Ingo Lehrke: Chief Executive Officer
About the Company
Algiax Pharmaceuticals GmbH is an independent biotechnology company that was established in April 2011. It is dedicated to the discovery and development of innovative products in the field of nervous system disease or dysfunction with a strong focus on neuropathic pain. The company is financially stable having raised 4,3 million Euro’s in Series A
financing from a consortium of private and state-backed investors.
